Armistice Capital, LLC Vertex Pharmaceuticals Inc Transaction History

Armistice Capital, LLC

$7.69 Billion
Q2 2024

A detailed history of Armistice Capital, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Armistice Capital, LLC holds 36,059 shares of VRTX stock, worth $18.1 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

36,059

Previous 51,980 30.63%

Holding current value

$18.1 Million

Previous $21.7 Million 22.22%

% of portfolio

0.22%

Previous 0.3%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $6.25 Million - $7.73 Million	-15,921 Reduced 30.63%	36,059 $16.9 Million
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $18.8 Million - $20.5 Million	-46,020 Reduced 46.96%	51,980 $21.7 Million
Q4 2023 Feb 13, 2024	SELL	$343.0 - $410.68 $6.21 Million - $7.44 Million	-18,117 Reduced 15.6%	98,000 $39.9 Million
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $2.67 Million - $2.86 Million	-7,883 Reduced 6.36%	116,117 $40.4 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $30.2 Million - $33.8 Million	-96,000 Reduced 43.64%	124,000 $43.6 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $20.4 Million - $23.3 Million	72,000 Added 48.65%	220,000 $69.3 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $571,520 - $642,960	-2,000 Reduced 1.33%	148,000 $42.7 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $44.4 Million - $49.5 Million	-162,000 Reduced 51.92%	150,000 $43.4 Million
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $17.9 Million - $22.2 Million	76,000 Added 32.2%	312,000 $87.9 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $55.8 Million - $65.8 Million	-252,000 Reduced 51.64%	236,000 $61.6 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $26.2 Million - $33.1 Million	-148,000 Reduced 23.27%	488,000 $107 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $6.53 Million - $7.31 Million	36,000 Added 6.0%	636,000 $115 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $39 Million - $46 Million	208,000 Added 53.06%	600,000 $121 Million
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $81.2 Million - $94.6 Million	392,000 New	392,000 $84.2 Million
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $13 Million - $16.1 Million	-65,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $5.83 Million - $7.84 Million	35,000 Added 116.67%	65,000 $14.2 Million
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $4.99 Million - $5.61 Million	30,000 New	30,000 $5.08 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Account

Armistice Capital, LLC Vertex Pharmaceuticals Inc Transaction History